Early Alzheimer's Prevention Promising Drug Trial Delays Onset

The Knight Family Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU) study, spearheaded by Washington University School of Medicine in St. Louis, has provided the first clinical trial evidence supporting the amyloid hypothesis. This hypothesis proposes that the accumulation of amyloid plaques in the brain is the initial trigger in the development of Alzheimer's disease. What's so remarkable about this study? It focused on individuals genetically destined to develop early-onset Alzheimer's, offering a unique opportunity to test preventative strategies.

Видео Early Alzheimer's Prevention Promising Drug Trial Delays Onset канала dailymotivational